{"transactions":[{"id":4614368,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-10T11:30:38.000Z","date":"2026-09-09","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.14,"value":214000.0,"ownership":{"direct":true},"balance_after":121357,"source":{"system":"sec-edgar","filing":"0001140361-26-036125","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000114036126036125/form4.xml","form_type":"4"}},{"id":671368,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T20:05:16.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":267160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date."}],"balance_after":267160,"derivative":{"exercise_price":2.12,"expiration_date":"2036-08-27","underlying":"Common Stock","underlying_shares":267160},"source":{"system":"sec-edgar","filing":"0001140361-26-035319","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000114036126035319/form4.xml","form_type":"4"}},{"id":1171101,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-17T00:58:49.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":225400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":225400,"derivative":{"exercise_price":2.08,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":225400},"source":{"system":"sec-edgar","filing":"0001140361-25-014263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000114036125014263/form4.xml","form_type":"4"}},{"id":1523510,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-08T23:18:18.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":128770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period."}],"balance_after":128770,"derivative":{"exercise_price":2.96,"expiration_date":"2034-05-06","underlying":"Class A Common Shares","underlying_shares":128770},"source":{"system":"sec-edgar","filing":"0000950170-24-056081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000095017024056081/ownership.xml","form_type":"4"}},{"id":1703497,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-20T21:05:27.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant."}],"balance_after":41668,"derivative":{"exercise_price":2.125,"expiration_date":"2033-12-19","underlying":"Class A Common Shares","underlying_shares":41668},"source":{"system":"sec-edgar","filing":"0000950170-23-071875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000095017023071875/ownership.xml","form_type":"4"}},{"id":1827966,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":18014,"kind":"person","name":"Kohli Prashant","position":1,"cik":"0001946739","reported_name":"Kohli Prashant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-18T20:26:07.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":208334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months."}],"balance_after":208334,"derivative":{"exercise_price":2.64,"expiration_date":"2033-07-14","underlying":"Class A Common Shares","underlying_shares":208334},"source":{"system":"sec-edgar","filing":"0001062993-23-014994","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946739/000106299323014994/form4.xml","form_type":"4"}}]}